East Timor Technology Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on East Timor Technology Press.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 20, 2025

October 20, 2025

Youxin Technology Ltd Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

October 20, 2025

XRP plunges, gold fluctuates, and Bitcoin stalls? Smart money is turning to NB HASH RWA — the next big thing is here!

GlobeNewswire

October 20, 2025

One thing smart retirement investors are doing: letting their pensions grow automatically on NB HASH RWA

GlobeNewswire

October 20, 2025

Genius Group CEO Roger Hamilton buys additional shares, increasing 2025 share purchases by 17%.

GlobeNewswire

October 20, 2025

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

GlobeNewswire

October 20, 2025

SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

GlobeNewswire

October 20, 2025

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

GlobeNewswire

October 20, 2025

QuickTopUps.com: Global Digital Recharge Platform launches in Pakistan to Broaden Access to Online Entertainment

GlobeNewswire

October 20, 2025

Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program

GlobeNewswire

October 20, 2025

Communiqué de presse : L’autorisation de Sanofi pour Tzield a été acceptée aux États-Unis pour le diabète de type 1 de stade 3 dans le cadre du programme pilote du voucher national de priorité du Commissaire de la FDA

GlobeNewswire

October 20, 2025

Lantronix Unveils Kompress.ai by Lantronix, an AI-Powered Platform That Optimizes Performance in Energy-Intensive Industries Using Vodafone IoT’s Connectivity

GlobeNewswire

October 20, 2025

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025

GlobeNewswire

October 20, 2025

Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025

GlobeNewswire

October 20, 2025

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

GlobeNewswire

October 20, 2025

Mutuum Finance (MUTM) Nears V1 Protocol Launch With Over 17,300 Investors in Q4 2025

GlobeNewswire

October 20, 2025

Respecting the Market and Pursuing a Long-Term Vision: SunPerp Doubles Its Depth to Build the "Newest, Best, and Most Stable" Futures Platform

GlobeNewswire

October 20, 2025

OGRD Alliance Expands OncoVix and PLPC-DB Initiatives from the Emirates to Asia and MENA Regions

GlobeNewswire

October 20, 2025

Kraig Biocraft Laboratories Launches Its Sixth 2025 Spider Silk Production Cycle, Introducing the Next Evolution of Its BAM-1 Alpha Recombinant Silk Platform

GlobeNewswire

October 20, 2025

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt

GlobeNewswire

October 20, 2025

New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week

GlobeNewswire